Lv7
3588 积分 2022-08-08 加入
Phase 1 clinical trial to assess safety and efficacy of NY-ESO-1-specific TCR T cells in HLA-A∗02:01 patients with advanced soft tissue sarcoma
2个月前
已完结
Structure-based programming of lymph-node targeting in molecular vaccines
2个月前
已完结
IL-7/IL-15/IL-21 cytokine-fusion scaffold generates highly functional CAR T cells enriched in long-lived T memory stem cells
3个月前
已完结
Personalized neoantigen vaccine combined with PD-1 blockade increases CD8+ tissue-resident memory T-cell infiltration in preclinical hepatocellular carcinoma models
4个月前
已完结
Multimodal AI generates virtual population for tumor microenvironment modeling
6个月前
已完结
Personalized neoantigen vaccine NEO-PV-01 with chemotherapy and anti-PD-1 as first-line treatment for non-squamous non-small cell lung cancer
8个月前
已完结
A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer
8个月前
已完结
An immunogenic personal neoantigen vaccine for patients with melanoma
8个月前
已完结
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
8个月前
已完结
Harnessing alternative splicing for off-the-shelf mRNA neoantigen vaccines in hepatocellular carcinoma
8个月前
已完结
皖公网安备34019202002308
